PRP4K protein expression is highly variable in tumour cells from various cancers, and reduced PRP4K expression in breast and ovarian cancer correlates with worse overall survival in several studies (Corkery et al., 2015b; Cho et al., 2018; Corkery et al., 2018). Here, PRP4K is linked to ovarian carcinoma.